The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...
But it wasn't until he started to feel an odd pain that he thought something was off, too. "I started to get a little bit of upper right rib cage pain that I thought was an abdominal muscle," he says.
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results